Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) signed a letter of intent to acquire remaining 20% stake in Hebei Tangren Pharmacy Co.,Ltd. on April 26, 2024. Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) entered into an agreement to acquire remaining 20% stake in Hebei Tangren Pharmacy Co.,Ltd. on May 20, 2024.

Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) completed the acquisition of remaining 20% stake in Hebei Tangren Pharmacy Co.,Ltd. on June 1, 2024. Hebei Tangren Pharmacy Co.,Ltd has become a wholly-owned subsidiary of Jianzhijia Pharmaceutical Chain Group Co., Ltd.